TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 24295397

Group type: EXPERIMENTAL
Intervention: Road Map (RM) protocol-based lifestyle program, including 3-4 consultations by a practice nurse within one year.
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Road Map (RM) protocol-based lifestyle program.
Number of subjects: 240

Group type: COMPARATOR
Intervention: Care as usual (control group).
Number of subjects: 240
Study: 21407129

Group type: EXPERIMENTAL
Intervention: Plus intervention
Number of subjects: 699

Group type: EXPERIMENTAL
Intervention: Basic intervention
Number of subjects: 699
Study: 19765280

Group type: EXPERIMENTAL
Intervention: ALARM International Program (AIP) intervention including educational outreach visits and facility-based maternal death reviews; duration: 2 years
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 46
Study: 17577465

Group type: EXPERIMENTAL
Intervention: Parecoxib 40 mg BID
Number of subjects: 26

Group type: COMPARATOR
Intervention: Dipyrone 1000 mg QID
Number of subjects: 26
Study: 15684245

Group type: EXPERIMENTAL
Intervention: In-patient comprehensive geriatric assessment (CGA)
Number of subjects: 10427

Group type: EXPERIMENTAL
Intervention: Ward-based management units
Number of subjects: 10427

Group type: EXPERIMENTAL
Intervention: Team-based care
Number of subjects: 10427
Study: 11278228

Group type: EXPERIMENTAL
Intervention: Earle's+AA
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: K-SCIM
Number of subjects: 129

Group type: COMPARATOR
Intervention: Earle's+Gln
Number of subjects: 129
Study: 9874915

Group type: EXPERIMENTAL
Intervention: Ambivalence about spouses
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Initial grief and distress
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bereaved participants
Number of subjects: 0
Study: 9279198

Group type: EXPERIMENTAL
Intervention: Head-up tilting at 20 degrees, 40 degrees, and 60 degrees
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Head-up tilting at 10 min and 45 min
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Head-up tilting
Number of subjects: 16
Study: 1827075

Group type: EXPERIMENTAL
Intervention: Laparoscopy
Number of subjects: 105

Group type: COMPARATOR
Intervention: Laparotomy
Number of subjects: 105
Study: 7036196

Group type: EXPERIMENTAL
Intervention: Isocarboxazid (Marplan) 20 mg daily, increased to achieve 90% platelet MAO inhibition
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 31757473

Group type: EXPERIMENTAL
Intervention: Omission of gastric residuals
Number of subjects: 143

Group type: COMPARATOR
Intervention: Prefeed gastric residuals
Number of subjects: 143
Study: 30928020

Group type: EXPERIMENTAL
Intervention: Platelet treatment
Number of subjects: 69

Group type: COMPARATOR
Intervention: TGF-β type I receptor (TβR I) inhibitor A83-01
Number of subjects: 69
Study: 27384245

Group type: EXPERIMENTAL
Intervention: Sustained Lung Inflation (SLI)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Conventional Bag/Mask Inflation (CBMI)
Number of subjects: 112
Study: 25378647

Group type: EXPERIMENTAL
Intervention: Sublingual fentanyl (low dose, 1/50th of rescue morphine dose)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Sublingual fentanyl (high dose, 1/25th of rescue morphine dose)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51

Group type: COMPARATOR
Intervention: Oral morphine (active control)
Number of subjects: 51
Study: 24421214

Group type: EXPERIMENTAL
Intervention: Pentaerythrityl-tetranitrate (PETN)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111
Study: 22561296

Group type: EXPERIMENTAL
Intervention: Supplementation with omega-3 polyunsaturated fatty acid (PUFA) and vitamins C and E
Number of subjects: 152

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 152
Study: 19170908

Group type: EXPERIMENTAL
Intervention: Radiofrequency catheter ablation (RF)
Number of subjects: 33
Study: 17202547

Group type: EXPERIMENTAL
Intervention: rTMS
Number of subjects: 46

Group type: COMPARATOR
Intervention: ECT
Number of subjects: 46
Study: 15203809

Group type: EXPERIMENTAL
Intervention: Bupropion treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Small lapses during treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Small lapses during follow-up
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Interaction between drug treatment and lapse history
Number of subjects: 0
Study: 11943448

Group type: EXPERIMENTAL
Intervention: Subcutaneous interleukin-2 (IL-2) plus antiretroviral therapy
Number of subjects: 4000

Group type: COMPARATOR
Intervention: Antiretroviral therapy alone
Number of subjects: 4000
Study: 8464953

Group type: EXPERIMENTAL
Intervention: 60 lux light therapy
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: 600 lux light therapy
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: 3500 lux light therapy
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: All three intensities of light therapy
Number of subjects: 105
Study: 3515509

Group type: EXPERIMENTAL
Intervention: Oral rehydration salts (ORS) from effervescent tablets containing citrate
Number of subjects: 115

Group type: COMPARATOR
Intervention: WHO recommended ORS
Number of subjects: 115

Group type: COMPARATOR
Intervention: WHO ORS
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Citrate containing ORS
Number of subjects: 115
Study: 30768195

Group type: EXPERIMENTAL
Intervention: Tai Ji Quan: Moving for Better Balance (TJQMBB)
Number of subjects: 670

Group type: EXPERIMENTAL
Intervention: Multimodal exercise
Number of subjects: 670

Group type: COMPARATOR
Intervention: Stretching exercise
Number of subjects: 670
Study: 29996817

Group type: EXPERIMENTAL
Intervention: Multi-component intervention to increase implementation of a healthy canteen policy
Number of subjects: 173
Study: 27654733

Group type: EXPERIMENTAL
Intervention: Topical dexamethasone (0.1% eye drops)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Sub-tenon triamcinolone injection (40mg/1ml)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 108
Study: 25351352

Group type: EXPERIMENTAL
Intervention: Light meal (breakfast)
Number of subjects: 17
Study: 22564997

Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX), Cisplatin (CDP), Doxorubicin (ADM) with Ifosfamide (IFO) (arm B)
Number of subjects: 246

Group type: COMPARATOR
Intervention: Methotrexate (MTX), Cisplatin (CDP), Doxorubicin (ADM) without Ifosfamide (IFO) (arm A)
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: Both arms (A and B)
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: Arm B (with IFO)
Number of subjects: 246
Study: 20970749

Group type: EXPERIMENTAL
Intervention: Incentive spirometry (IS) for 10 breaths, 5 times per day
Number of subjects: 41

Group type: COMPARATOR
Intervention: Incentive spirometry (IS) for 3 breaths, once per day (Control)
Number of subjects: 41
Study: 18585771

Group type: EXPERIMENTAL
Intervention: Special training condition
Number of subjects: 16

Group type: COMPARATOR
Intervention: Standard training condition
Number of subjects: 16
Study: 16042234

Group type: EXPERIMENTAL
Intervention: MS group (patients with MS)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Cane‐assisted group
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Nonassisted group
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (20 healthy subjects)
Number of subjects: 100
Study: 12415457

Group type: EXPERIMENTAL
Intervention: Immediate feeding (within 1 hour)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Next-day feeding (24 hours after procedure)
Number of subjects: 80
Study: 10606453

Group type: EXPERIMENTAL
Intervention: External beam irradiation (seven treatment sessions)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Sham radiation (one sham treatment session)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 73
Study: 8948386

Group type: EXPERIMENTAL
Intervention: Oat bran concentrate bread products
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control white bread
Number of subjects: 8
Study: 2059103

Group type: EXPERIMENTAL
Intervention: Electric stimulation
Number of subjects: 59

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 59
Study: 6381884

Group type: EXPERIMENTAL
Intervention: Chemo-hormonal regimen for first recurrence
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Entire group
Number of subjects: 194
Study: 31477558

Group type: EXPERIMENTAL
Intervention: Aspirin 100 mg daily for 8 weeks (run-in phase)
Number of subjects: 3494

Group type: COMPARATOR
Intervention: Aspirin 100 mg or 300 mg or matched placebo (double-blind randomisation)
Number of subjects: 3494
Study: 29972709

Group type: EXPERIMENTAL
Intervention: Periodontal treatment
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 52
Study: 27049446

Group type: EXPERIMENTAL
Intervention: Tai Chi exercise (n = 22)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (n = 21)
Number of subjects: 43
Study: 25172777

Group type: EXPERIMENTAL
Intervention: Doxycycline 200 mg
Number of subjects: 641

Group type: COMPARATOR
Intervention: Control (no doxycycline)
Number of subjects: 641
Study: 23032589

Group type: EXPERIMENTAL
Intervention: Reamed intramedullary nailing
Number of subjects: 1226

Group type: EXPERIMENTAL
Intervention: Stainless steel nail
Number of subjects: 1226

Group type: EXPERIMENTAL
Intervention: Fracture gap
Number of subjects: 1226

Group type: EXPERIMENTAL
Intervention: Full weight-bearing status after surgery
Number of subjects: 1226

Group type: EXPERIMENTAL
Intervention: Reamed nailing
Number of subjects: 1226

Group type: EXPERIMENTAL
Intervention: Unreamed nailing
Number of subjects: 1226

Group type: EXPERIMENTAL
Intervention: Wound management without additional procedures
Number of subjects: 1226

Group type: EXPERIMENTAL
Intervention: Wound management with delayed primary closure
Number of subjects: 1226
Study: 20977368

Group type: EXPERIMENTAL
Intervention: Linezolid 600 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Levofloxacin 750 mg
Number of subjects: 16
Study: 17692271

Group type: EXPERIMENTAL
Intervention: Valacyclovir (500 mg tablet daily)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Acyclovir (400 mg tablet twice daily)
Number of subjects: 52
Study: 15679567

Group type: EXPERIMENTAL
Intervention: Structured intervention exercise program (one session per week, 90 min, for 1 year)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Follow-up program or other programs of the same club (after initial 12 months)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Control group (not specified intervention)
Number of subjects: 117
Study: 11953546

Group type: COMPARATOR
Intervention: Functional Electric Stimulation (FES) therapy for short-duration hemiplegia, 6 hours a day for 6 weeks.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Functional Electric Stimulation (FES) therapy for long-duration hemiplegia, 6 hours a day for 6 weeks.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Second 6-week FES therapy after the first 6-week therapy for both short and long-duration groups.
Number of subjects: 0
Study: 9525433

Group type: EXPERIMENTAL
Intervention: Nonoxynol-9 (N-9) 100 mg daily for 1 week
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 7650839

Group type: EXPERIMENTAL
Intervention: L-carnitine
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: DL-carnitine
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 19
Study: 2676652

Group type: EXPERIMENTAL
Intervention: 600 mg fenticonazole (single administration)
Number of subjects: 80

Group type: COMPARATOR
Intervention: 500 mg clotrimazole (single administration)
Number of subjects: 80
Study: 803977

Group type: EXPERIMENTAL
Intervention: 12 hr fast
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 36 hr fast
Number of subjects: 9
Study: 30584131

Group type: EXPERIMENTAL
Intervention: L-Arginine supplementation
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 29081128

Group type: EXPERIMENTAL
Intervention: High pressure oxygen and Butylphthalide
Number of subjects: 84

Group type: COMPARATOR
Intervention: Conventional therapy and high pressure oxygen (Control)
Number of subjects: 84
Study: 25935844

Group type: EXPERIMENTAL
Intervention: J‐Tip (lidocaine)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Vapocoolant spray (control)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Vapocoolant spray and pop of an empty J‐Tip (sham)
Number of subjects: 205
Study: 22537562

Group type: EXPERIMENTAL
Intervention: TENS
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control
Number of subjects: 15
Study: 19681772

Group type: EXPERIMENTAL
Intervention: LMA Supreme
Number of subjects: 138

Group type: COMPARATOR
Intervention: ETT
Number of subjects: 138
Study: 19079970

Group type: EXPERIMENTAL
Intervention: Preimplantation genetic screening (PGS)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Conventional assisted reproduction treatment (Control)
Number of subjects: 200
Study: 15823628

Group type: EXPERIMENTAL
Intervention: Intensive treatment with diet, anti-hypertensive or antidiabetic drugs
Number of subjects: 238

Group type: COMPARATOR
Intervention: Control group referred to general practitioner
Number of subjects: 238
Study: 12092978

Group type: EXPERIMENTAL
Intervention: Antioxidant mixture (vitamin E, beta-carotene, ascorbic acid, selenium, alpha-lipoic acid, N-acetyl 1-cysteine, catechin, lutein, lycopene)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 10709527

Group type: EXPERIMENTAL
Intervention: Procera system (titanium copings veneered with a low‐fusing ceramic)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Noble-alloy copings veneered with a medium‐fusing ceramic
Number of subjects: 18
Study: 8746880

Group type: EXPERIMENTAL
Intervention: 0.5 mg estriol vaginal suppositories
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: 1.0 mg estriol vaginal suppositories
Number of subjects: 72
Study: 1974723

Group type: EXPERIMENTAL
Intervention: Sulphasalazine
Number of subjects: 200

Group type: COMPARATOR
Intervention: Penicillamine
Number of subjects: 200
Study: 6167093

Group type: EXPERIMENTAL
Intervention: Acute excision and grafting in the shock-phase
Number of subjects: 0

Group type: COMPARATOR
Intervention: Exposure for about 14 days, followed by excision and grafting
Number of subjects: 0
Study: 28779007

Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 68

Group type: COMPARATOR
Intervention: Dexamethasone implants
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Central macular thickness change
Number of subjects: 68
Study: 29944242

Group type: EXPERIMENTAL
Intervention: E2 supplementation during the luteal phase
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 24757918

Group type: EXPERIMENTAL
Intervention: High-fidelity simulation (HFS)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Traditional static mannequins
Number of subjects: 33
Study: 22648841

Group type: EXPERIMENTAL
Intervention: Enteral Nutrition (EN)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HIIC + Enteral Nutrition (HIIC+EN)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HIIC + Parenteral Nutrition (HIIC+PN)
Number of subjects: 0
Study: 20931801

Group type: EXPERIMENTAL
Intervention: Oral contraceptive drospirenone/ethinyl E2 (group 1)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Norelgestromin/ethinyl E2 transdermal patch (group 2)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Vaginal ring etonogestrel/ethinyl E2 (group 3)
Number of subjects: 120
Study: 18408604

Group type: EXPERIMENTAL
Intervention: Slow-velocity (S: 30 degrees.s(‐1))
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Fast-velocity (F: 210 degrees.s(‐1))
Number of subjects: 16

Group type: COMPARATOR
Intervention: 30 maximal lengthening contractions
Number of subjects: 16

Group type: COMPARATOR
Intervention: 210 maximal lengthening contractions
Number of subjects: 16
Study: 15909743

Group type: EXPERIMENTAL
Intervention: PET
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: MRI
Number of subjects: 17

Group type: COMPARATOR
Intervention: Both techniques
Number of subjects: 17
Study: 12743232

Group type: EXPERIMENTAL
Intervention: Interferon beta-1b (IFNbeta-1b)
Number of subjects: 0
Study: 10319572

Group type: EXPERIMENTAL
Intervention: Mailed advice intervention (individualized letters sent to subjects)
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Mailed advice intervention
Number of subjects: 226

Group type: COMPARATOR
Intervention: Control group (no mailed advice)
Number of subjects: 226
Study: 8571209

Group type: EXPERIMENTAL
Intervention: Modified Sugiura procedure
Number of subjects: 54

Group type: COMPARATOR
Intervention: Portal systemic shunt
Number of subjects: 54
Study: 2020272

Group type: EXPERIMENTAL
Intervention: Naloxone (20 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 10
Study: 7037756

Group type: EXPERIMENTAL
Intervention: Trimipramine
Number of subjects: 41

Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 41
Study: 30658632

Group type: EXPERIMENTAL
Intervention: Prenatal nutrient supplementation with iron and folic acid
Number of subjects: 601

Group type: EXPERIMENTAL
Intervention: Pre- and postnatal multiple micronutrients
Number of subjects: 601

Group type: EXPERIMENTAL
Intervention: Lipid-based nutrient supplements
Number of subjects: 601

Group type: COMPARATOR
Intervention: Control group (aparasitaemic children)
Number of subjects: 601
Study: 28062296

Group type: EXPERIMENTAL
Intervention: 40mg pravastatin for 1 year
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: 40mg rosuvastatin
Number of subjects: 79

Group type: COMPARATOR
Intervention: Atorvastatin after 8 weeks
Number of subjects: 79
Study: 27035871

Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 107

Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 107
Study: 25091668

Group type: EXPERIMENTAL
Intervention: Withholding breastfeeding during the 30 min prior to and after each vaccine dose
Number of subjects: 400

Group type: COMPARATOR
Intervention: Breastfeeding during the 30 min prior to and after each vaccine dose
Number of subjects: 400
Study: 22815003

Group type: EXPERIMENTAL
Intervention: Esmolol drip (0.2‐0.5 mg/kg bolus followed by continuous infusion of 212.5 ± 63.5 mg/h to 272.5 ± 89.5 mg/h over 24 hours)
Number of subjects: 10
Study: 19639105

Group type: EXPERIMENTAL
Intervention: 1% capsaicin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle cream
Number of subjects: 0
Study: 17156345

Group type: EXPERIMENTAL
Intervention: Combined topical steroid (extra-fine inhaled beclomethasone 400 mcg/day and intranasal beclomethasone 200 mcg/day)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Combined mediator antagonism (montelukast 10 mg and cetirizine 10 mg)
Number of subjects: 17
Study: 16037733

Group type: EXPERIMENTAL
Intervention: Sevoflurane-fentanyl (group S)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Propofol-remifentanil (group T)
Number of subjects: 120
Study: 11952053

Group type: EXPERIMENTAL
Intervention: Lower body negative pressure (LBNP) sessions at -30 mm Hg for 1 hour per day from day 15 to day 21 of HDT.
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (no LBNP sessions).
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both groups during HDT.
Number of subjects: 12
Study: 10612317

Group type: EXPERIMENTAL
Intervention: Adefovir dipivoxil (120 mg/d)
Number of subjects: 442

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 442
Study: 7675241

Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg/hr levodopa infusion
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 1.0 mg/kg/hr levodopa infusion
Number of subjects: 8

Group type: COMPARATOR
Intervention: 0.0 mg/kg/hr levodopa infusion (placebo)
Number of subjects: 8
Study: 2276391

Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 7002059

Group type: EXPERIMENTAL
Intervention: Intrathecal antitetanus serum with steroid
Number of subjects: 107

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Intrathecal antitetanus serum
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Intrathecal antitetanus serum (100 units or 50 units)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Test group
Number of subjects: 107
Study: 31827347

Group type: EXPERIMENTAL
Intervention: Interval training (INT) - alternating 3min at 90% HRpeak and 3min at 50% HRpeak for 12 sessions (60min each) over two weeks
Number of subjects: 22

Group type: COMPARATOR
Intervention: Continuous training (CONT) - 70% HRpeak for 12 sessions (60min each) over two weeks
Number of subjects: 22
Study: 27152427

Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control (Normal Saline)
Number of subjects: 160
Study: 26391630

Group type: EXPERIMENTAL
Intervention: Peer educators intervention
Number of subjects: 2342

Group type: COMPARATOR
Intervention: Control (no peer educators)
Number of subjects: 2342
Study: 24565542

Group type: EXPERIMENTAL
Intervention: Combination budesonide/formoterol as maintenance and reliever therapy
Number of subjects: 150

Group type: COMPARATOR
Intervention: Combination budesonide/formoterol as maintenance treatment with albuterol as reliever
Number of subjects: 150
Study: 21558771

Group type: EXPERIMENTAL
Intervention: Ertapenem use
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alcohol-based hand sanitizer
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Imipenem or meropenem
Number of subjects: 0
Study: 18829212

Group type: EXPERIMENTAL
Intervention: Music intervention for CPAP adherence, including audiotape with instructions and music, used nightly for 1 month.
Number of subjects: 97

Group type: COMPARATOR
Intervention: Placebo control group, no specific intervention details provided.
Number of subjects: 97
Study: 17567342

Group type: EXPERIMENTAL
Intervention: Naloxone 400 microg
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 15477125

Group type: COMPARATOR
Intervention: Salbutamol (100 microg every 6 h)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Formoterol (12 microg every 12 h)
Number of subjects: 12
Study: 11684081

Group type: EXPERIMENTAL
Intervention: Transdermal nicotine
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 10396923

Group type: EXPERIMENTAL
Intervention: Regular outpatient treatment (3 months)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Extended outpatient treatment (6 months)
Number of subjects: 0